280 related articles for article (PubMed ID: 24878851)
41. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
42. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.
Wang J; Ouyang Y; Guner Y; Ford HR; Grishin AV
J Immunol; 2009 Jul; 183(2):1384-92. PubMed ID: 19570823
[TBL] [Abstract][Full Text] [Related]
43. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation.
Iha H; Peloponese JM; Verstrepen L; Zapart G; Ikeda F; Smith CD; Starost MF; Yedavalli V; Heyninck K; Dikic I; Beyaert R; Jeang KT
EMBO J; 2008 Feb; 27(4):629-41. PubMed ID: 18239685
[TBL] [Abstract][Full Text] [Related]
44. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis.
Matmati M; Jacques P; Maelfait J; Verheugen E; Kool M; Sze M; Geboes L; Louagie E; Mc Guire C; Vereecke L; Chu Y; Boon L; Staelens S; Matthys P; Lambrecht BN; Schmidt-Supprian M; Pasparakis M; Elewaut D; Beyaert R; van Loo G
Nat Genet; 2011 Aug; 43(9):908-12. PubMed ID: 21841782
[TBL] [Abstract][Full Text] [Related]
45. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
[TBL] [Abstract][Full Text] [Related]
46. A20 promotes Brucella intracellular growth via inhibition of macrophage cell death and activation.
Wei P; Cui G; Lu Q; Yang L; Guan Z; Sun W; Zhao Y; Wang S; Peng Q
Vet Microbiol; 2015 Jan; 175(1):50-7. PubMed ID: 25433453
[TBL] [Abstract][Full Text] [Related]
47. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling.
Bosanac I; Wertz IE; Pan B; Yu C; Kusam S; Lam C; Phu L; Phung Q; Maurer B; Arnott D; Kirkpatrick DS; Dixit VM; Hymowitz SG
Mol Cell; 2010 Nov; 40(4):548-57. PubMed ID: 21095585
[TBL] [Abstract][Full Text] [Related]
48. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
[TBL] [Abstract][Full Text] [Related]
49. A20 Inhibits LPS-Induced Inflammation by Regulating TRAF6 Polyubiquitination in Rainbow Trout.
Jang JH; Kim H; Jung IY; Cho JH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575978
[TBL] [Abstract][Full Text] [Related]
50. An anti-inflammatory role of A20 zinc finger protein during trauma combined with endotoxin challenge.
Liu B; Jiang D; Ou Y; Hu Z; Jiang J; Lei X
J Surg Res; 2013 Dec; 185(2):717-25. PubMed ID: 24055365
[TBL] [Abstract][Full Text] [Related]
51. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.
Ning S; Pagano JS
J Virol; 2010 Jun; 84(12):6130-8. PubMed ID: 20392859
[TBL] [Abstract][Full Text] [Related]
52. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
53. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
54. Bcl10 is an essential regulator for A20 gene expression.
Xu W; Xue L; Sun Y; Henry A; Battle JM; Micault M; Morris SW
J Physiol Biochem; 2013 Dec; 69(4):821-34. PubMed ID: 23677497
[TBL] [Abstract][Full Text] [Related]
55. The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling.
Garg AV; Ahmed M; Vallejo AN; Ma A; Gaffen SL
Sci Signal; 2013 Jun; 6(278):ra44. PubMed ID: 23737552
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme.
Liu X; He F; Pang R; Zhao D; Qiu W; Shan K; Zhang J; Lu Y; Li Y; Wang Y
J Biol Chem; 2014 Oct; 289(42):28971-86. PubMed ID: 25183005
[TBL] [Abstract][Full Text] [Related]
57. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.
Hitotsumatsu O; Ahmad RC; Tavares R; Wang M; Philpott D; Turer EE; Lee BL; Shiffin N; Advincula R; Malynn BA; Werts C; Ma A
Immunity; 2008 Mar; 28(3):381-90. PubMed ID: 18342009
[TBL] [Abstract][Full Text] [Related]
58. Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells.
Munitic I; Giardino Torchia ML; Meena NP; Zhu G; Li CC; Ashwell JD
J Immunol; 2013 Dec; 191(12):6231-40. PubMed ID: 24244017
[TBL] [Abstract][Full Text] [Related]
59. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
60. β(2) integrins inhibit TLR responses by regulating NF-κB pathway and p38 MAPK activation.
Yee NK; Hamerman JA
Eur J Immunol; 2013 Mar; 43(3):779-92. PubMed ID: 23310953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
